K vs RARE · P/E 23, $29.03B cap vs rev $350.0M
Kellanova (K) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
K does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
K currently screens at market cap $29.03B and trailing P/E 22.8. RARE currently screens at market cap $2.79B.
Not investment advice. Open the K and RARE stock pages for the full models.
Not investment advice.